Astrazeneca PLC

54.01+0.7600+1.43%Vol 13.71M1Y Perf 9.41%
Jan 25th, 2021 16:00 DELAYED
BID53.79 ASK53.99
Open53.73 Previous Close53.25
Pre-Market54.39 After-Market-
 0.38 0.70%  - -
Target Price
63.85 
Analyst Rating
Strong Buy 1.33
Potential %
18.22 
Finscreener Ranking
★★★     49.75
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
     42.93
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★★     59.68
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
     23.91
Market Cap141.75B 
Earnings Rating
Buy
Price Range Ratio 52W %
62.04 
Earnings Date
11th Feb 2021

Today's Price Range

53.5954.21

52W Range

36.1564.94

5 Year PE Ratio Range

19.2074.90

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
2.74%
1 Month
11.31%
3 Months
1.77%
6 Months
-2.45%
1 Year
9.41%
3 Years
47.45%
5 Years
75.11%
10 Years
187.62%

TickerPriceChg.Chg.%
AZN54.010.76001.43
AAPL142.923.85002.77
GOOG1 899.40-1.6500-0.09
MSFT229.533.58001.58
XOM46.90-0.5300-1.12
WFC32.240.34001.07
JNJ165.982.43001.49
FB278.013.51001.28
GE10.99-0.1200-1.08
JPM132.12-1.6700-1.25
Financial StrengthValueIndustryS&P 500US Markets
0.40
1.00
0.61
1.83
3.30
Leverage Ratio 5.10
ProfitabilityValueIndustryS&P 500US Markets
80.10
16.60
32.00
9.40
11.14
RevenueValueIndustryS&P 500US Markets
18.32B
6.98
-1.62
-1.00
DividendsValueIndustryS&P 500US Markets
1.67
0.90
0.00
0.00
Payout ratio167.00
Earnings HistoryEstimateReportedSurprise %
Q03 20200.490.47-4.08
Q02 20200.440.489.09
Q01 20200.470.5312.77
Q04 20190.530.45-15.09
Q03 20190.450.5011.11
Q02 20190.300.73143.33
Q01 20190.430.454.65
Q04 20180.731.58116.44
Earnings Per EndEstimateRevision %Trend
12/2020 QR0.53-3.64Negative
12/2020 QR0.553.77Positive
12/2020 FY2.01-0.50Negative
12/2021 FY2.590.78Positive
Next Report Date11th Feb 2021
Estimated EPS Next Report0.53
Estimates Count3
EPS Growth Next 5 Years %16.80
Volume Overview
Volume13.71M
Shares Outstanding2.62B
Trades Count73.25K
Dollar Volume712.43M
Avg. Volume12.58M
Avg. Weekly Volume13.71M
Avg. Monthly Volume12.57M
Avg. Quarterly Volume10.50M

Astrazeneca PLC (NYSE: AZN) stock closed at 54.01 per share at the end of the most recent trading day (a 1.43% change compared to the prior day closing price) with a volume of 13.74M shares and market capitalization of 141.75B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 64600 people. Astrazeneca PLC CEO is Pascal Soriot.

The one-year performance of Astrazeneca PLC stock is 9.41%, while year-to-date (YTD) performance is 8.04%. AZN stock has a five-year performance of 75.11%. Its 52-week range is between 36.15 and 64.94, which gives AZN stock a 52-week price range ratio of 62.04%

Astrazeneca PLC currently has a PE ratio of 55.30, a price-to-book (PB) ratio of 11.31, a price-to-sale (PS) ratio of 7.74, a price to cashflow ratio of 31.50, a PEG ratio of 2.32, a ROA of 3.92%, a ROC of 10.73% and a ROE of 19.75%. The company’s profit margin is 11.14%, its EBITDA margin is 32.00%, and its revenue ttm is $18.32 Billion , which makes it $6.98 revenue per share.

Of the last four earnings reports from Astrazeneca PLC, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.53 for the next earnings report. Astrazeneca PLC’s next earnings report date is 11th Feb 2021.

The consensus rating of Wall Street analysts for Astrazeneca PLC is Strong Buy (1.33), with a target price of $63.85, which is +18.22% compared to the current price. The earnings rating for Astrazeneca PLC stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Astrazeneca PLC has a dividend yield of 1.67% with a dividend per share of $0.90 and a payout ratio of 167.00%.

Astrazeneca PLC has a Buy technical analysis rating based on Technical Indicators (ADX : 11.91, ATR14 : 3.02, CCI20 : 195.36, Chaikin Money Flow : 733.89, MACD : 0.47, Money Flow Index : 64.54, ROC : 7.61, RSI : 70.62, STOCH (14,3) : 95.23, STOCH RSI : 1.00, UO : 62.74, Williams %R : -4.77), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Astrazeneca PLC in the last 12-months were: Michel Demare (Buy at a value of $102 382), Nazneen Rahman (Buy at a value of $39 698), Philip A J Broadley (Buy at a value of $99 888), Tony Mok (Buy at a value of $172 640)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
4 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
1 (16.67 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Moderate Buy
2.00

Astrazeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing close to one third of its sales.

CEO: Pascal Soriot

Teplephone: +44 2037495000

Address: 1 Francis Crick Avenue, Cambridge CB2 0AA, , GBR

Number of employees: 64 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

51%49%

Bearish Bullish

48%52%

News

Stocktwits